November 26, 2014 10:36 AM ET

Pharmaceuticals

Company Overview of InfaCare Pharmaceutical Corporation

Company Overview

InfaCare Pharmaceutical Corporation develops and commercializes pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a pharmacological treatment for infantile jaundice or hyperbilirubinemia. The company was founded in 2005 and is based in Trevose, Pennsylvania.

8 Neshaminy Interplex

Suite 221

Trevose, PA 19053-6499

United States

Founded in 2005

Phone:

267-515-5850

Fax:

415-244-9830

Key Executives for InfaCare Pharmaceutical Corporation

Chief Executive Officer
Age: 62
Founder and Chairman
Age: 70
Chief Financial Officer
Chief Medical Officer
Board Observer
Age: 44
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
INVAMED Pharma Inc. United States
Angiogenix, Inc. United States
Nutrilite Health Institute United States
Diamyd Inc. United States
PMRS, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 20, 2014
--
Private Placement
June 4, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InfaCare Pharmaceutical Corporation, please visit www.infacare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.